Enlivex (NASDAQ: $ENLV) is The Quality Longevity Company, combining a clinical biotechnology platform with a prediction markets treasury strategy.

The company’s clinical engine is Allocetra™, an immunotherapy in development for aging-related diseases, initially focused on knee osteoarthritis.

Alongside its clinical program, Enlivex operates a prediction markets treasury via the Rain Protocol, creating a scalable capital engine designed to support the long-term development of new therapies.

Enlivex

Org chart

Teams

Offices

Enlivex

Org chart

Teams

Offices

Related companies